Extended release dosage form BE design [Design Issues]

posted by ssussu – China, 2017-08-29 13:38 (2424 d 06:17 ago) – Posting: # 17748
Views: 2,478

Dear all,
According to the FDA guidance for Mirabegron extended release tablets, there are 3 studies included. Why the study of 25mg strenth under fed condition dose not need?
Additionally, about a extended release drug,if the half life is very long e.g. 70hr,dose the AUC truncte to AUC0-72h?
Is there guidance for extended release drug specially from FDA?

Please kindly give me some advice. Thank you!

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,667 registered users;
56 visitors (0 registered, 56 guests [including 3 identified bots]).
Forum time: 19:55 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5